General Biological
PrivateLast Round
Seed
Dec 1, 2024
Total Funding Raised
$6.63M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
General Biological operates in Energy & Sustainability and is based in New Haven, Connecticut. Its latest recorded funding round was a Seed round in December 2024.
General Biological is an industrial biotechnology company developing a biomanufacturing platform to produce specialty chemicals and materials from renewable feedstocks.
Sector
Energy & Sustainability
Verticals
Biotechnology, Clean Manufacturing, Sustainable Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
General Biological Comparables
Compare General Biological with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Capra Biosciences | 85% | |
| Fermbox Bio | 81% | |
| Biosphere | 79% |
For institutional investors. Book with your work email.
General Biological Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2024 | ||||
| Grant | Mar 31, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
General Biological Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Yale Center for Business and the Environment | Grant |
| BoxGroup | Seed |
| Abstract Ventures | Seed |
| Lowercarbon Capital | Seed |
| CIV | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 26, 173% of headcount.
- Dec 1, 2024
Raised $6.6M from Lowercarbon Capital and Abstract Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- expands_facilitiesSep 15, 2026
General Biological Corporation seeks planning board approval to build a 51-acre facility in Berwick, Maine, as of Sep 15th '26.
For institutional investors. Book with your work email.
General Biological Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about General Biological's valuation, stock price, and market status.
Is General Biological a public or private company?
General Biological is a private company.
What is the current stock price of General Biological?
General Biological is a private company, so its shares have no public market price. Caplight tracks General Biological's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is General Biological worth (valuation)?
Valuation information for General Biological is not publicly available.
Can I buy General Biological stock?
General Biological shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was General Biological's last funding round?
General Biological's most recent funding round was Seed on December 1, 2024.
Who are the main investors in General Biological?
Key investors in General Biological include Yale Center for Business and the Environment, BoxGroup, Abstract Ventures, Lowercarbon Capital, CIV.
Will General Biological IPO soon?
No public IPO plans have been announced for General Biological.
How can I track General Biological secondary market activity?
Caplight tracks bids, offers, and trades in General Biological's shares on secondary markets.